Clinical Trials Sponsored by Dafna yahav

Total 1248 results

dafna yahav

Not yet recruiting

Booster Dose of COVID-19 Vaccine for Kidney Transplant Recipients Without Adequate Humoral Response (WHO)

Immunosuppression | COVID-19 Acute Respiratory Distress Syndrome
Dafra Pharma

Completed

Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria

Plasmodium Falciparum Malaria

Cameroon, Mali, Rwanda, Sudan
Dafra Pharma

Completed

Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis

Schistosoma Haematobium

Mali
Dana-Farber Cancer Institute

Recruiting

Feasibility and Preliminary Efficacy of Exercise During Immunotherapy in Patients With Lung Cancer: The INHALE Trial (INHALE)

Advanced Lung Cancer

United States
Dana-Farber Cancer Institute

Not yet recruiting

Peer Support Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation (STEPP)

Hematopoietic Malignancy | Hematopoietic Neoplasms

United States
Dana-Farber Cancer Institute

Recruiting

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Lung Cancer | Cirrhosis | Barrett Esophagus | Hematologic Malignancy | Non-Alcoholic Fatty Liver Disease | Cancer Risk | Vulvar Intraepithelial Neoplasia | Childhood Cancer Survivors | Lung; Node | Non Alcoholic Steatohepatitis | Osteochondroma | Cancer Predisposition Syndrome | Hereditary Cancer Prediction | Adult... and other conditions

United States
Dana-Farber Cancer Institute

Recruiting

Biology of Young Lung Cancer Study: The YOUNG LUNG Study

Small Cell Lung Carcinoma | Non Small Cell Lung Cancer

United States
Dana-Farber Cancer Institute

Recruiting

Urologic Lymphadenectomy in AMIGO

Urologic Cancer | Lymph Node Metastasis

United States
Dana-Farber Cancer Institute

Recruiting

IS-free Treg HaploHCT

Myelodysplastic Syndromes | Graft Vs Host Disease | Stem Cell Transplant Complications | Myeloid Leukemia, Acute | Myeloid Leukemia in Relapse (Disorder)

United States
Dana-Farber Cancer Institute

Recruiting

Resilience and Equity in Aging, Cancer, and Health (REACH) (REACH)

Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Gastrointestinal Cancer

United States
Dana-Farber Cancer Institute

Recruiting

Refining Local-Regional Therapy for IBC

Breast Cancer | Sentinel Lymph Node | Inflammatory Breast Cancer

United States
Dana-Farber Cancer Institute

Recruiting

Jump: MR Simulation For Radiation Therapy Master Protocol (JUMP)

Head and Neck Cancer | Prostate Cancer | Liver Cancer | Recurrent Adenocarcinoma

United States
Dana-Farber Cancer Institute

Recruiting

Serial MRI Scans During Radiation Therapy (RELAY)

MRI | Glioblastoma | Esophageal Cancer | Prostate Cancer | Vulvar Cancer | Magnetic Resonance Imaging | Radiotherapy | Pediatric Glioblastoma Multiforme

United States
Dana-Farber Cancer Institute

Recruiting

Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases

Brain Tumor

United States
Dana-Farber Cancer Institute

Recruiting

Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies

Liver Cancer

United States
Dana-Farber Cancer Institute

Active, not recruiting

The Young Women's Breast Cancer Study (HOHO)

Breast Cancer

United States, Canada
Dana-Farber Cancer Institute

Active, not recruiting

The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy

Flat Epithelia Atypia | Intraductal Papilloma Without Atypia

United States
Dana-Farber Cancer Institute

Enrolling by invitation

AWARENESS Trial (AWARENESS) of Storytelling Through Music in Healthcare Workers

Stress | Post Traumatic Stress Disorder | Work Related Stress

United States
Dana-Farber Cancer Institute

Enrolling by invitation

Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC) ((PATH-SIC))

Breast Cancer | Gynecologic Cancer | Thoracic Cancer | Gastrointestinal Cancer | Genitourinary Cancer

United States
Dana-Farber Cancer Institute

Active, not recruiting

Dendritic Cell Activating Scaffold in Melanoma

Melanoma

United States
Dana-Farber Cancer Institute

Suspended

CONFIRM: Magnetic Resonance Guided Radiation Therapy (CONFIRM)

Gastric Cancer | Mantle Cell Lymphoma | Bladder Cancer | Invasive Breast Cancer | Larynx Cancer | in Situ Breast Cancer

United States
Dana-Farber Cancer Institute

Active, not recruiting

Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma

Follicular Lymphoma

United States
Dana-Farber Cancer Institute

Completed

Eribulin in HER2 Negative Metastatic BrCa

Breast Cancer

United States
Dana-Farber Cancer Institute

Completed

Mathematical Model-Adapted Radiation In Glioblastoma

Recurrent Glioblastoma

United States
Dana-Farber Cancer Institute

Active, not recruiting

Fulvestrant With or Without Ganetespib in HR+ Breast Cancer

Breast Cancer

United States
Dana-Farber Cancer Institute

Completed

The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study

Myelodysplastic Syndromes (MDS)

United States
Dana-Farber Cancer Institute

Withdrawn

GROW (Glioma Specialists Reaching Out With Support) Support

Low-grade Glioma | Survivorship | Care Giving Burden

United States
Dana-Farber Cancer Institute

Completed

My Mindful Moments: A Mindfulness Meditation and Digital Art Activity

Meditation | Mindfulness

United States
Dana-Farber Cancer Institute

Completed

Image-guided Cryoablation of Head, Neck and Spine Tumors

Head and Neck Neoplasms | Malignant Neoplasm of Vertebral Column

United States
Dana-Farber Cancer Institute

Completed

Patient-Centered Care for the Older Adult With Hematologic Malignancy

Hematologic Malignancy

United States
Dana-Farber Cancer Institute

Completed

EHR-embedded OCDT in Breast or GI Cancer

Breast Cancer | Gastrointestinal Cancer | Oral Cancer Directed Therapy | Oral Chemotherapy

United States
Dana-Farber Cancer Institute

Completed

Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer

Early Stage Breast Cancer

United States
Dana-Farber Cancer Institute

Withdrawn

Dilute Bleach Compresses for Radiation Dermatitis

Radiation Dermatitis
Dana-Farber Cancer Institute

Terminated

Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

United States
Dana-Farber Cancer Institute

Completed

Post-Operative Ambulatory Challenge and Exercise (PACE) Trial

Cancer

United States
Dana-Farber Cancer Institute

Completed

Physical Activity In Gastrointestinal Cancer

Physical Activity | Metastatic Gastrointestinal Cancer

United States
Dana-Farber Cancer Institute

Completed

Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT

Multiple Myeloma

United States
Dana-Farber Cancer Institute

Terminated

BKM120+Abiraterone Acetate for Metastatic CRPC

Prostate Cancer

United States
Dana-Farber Cancer Institute

Completed

Sunitinib in Never-Smokers With Lung Adenocarcinoma

Lung Cancer

United States
Dana-Farber Cancer Institute

Terminated

An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease

Chronic Graft-versus-Host-Disease | Oral Mucosal Disease Due to Graft-versus-host Disease

United States
Dana-Farber Cancer Institute

Completed

Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment

Prostate Cancer | Adenocarcinoma of the Prostate

United States
Dana-Farber Cancer Institute

Terminated

Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study

Squamous Cell Carcinoma of the Head and Neck | Human Papilloma Virus

United States
Dana-Farber Cancer Institute

Completed

NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer

Esophageal Cancer

United States
Dana-Farber Cancer Institute

Withdrawn

Evaluation Of Lymph Nodes After Neoadjuvant Chemotherapy

Breast Cancer
Dana-Farber Cancer Institute

Terminated

Ruxolitinib in Patients With Breast Cancer

Breast Cancer

United States
Dana-Farber Cancer Institute

Completed

Image-guided Breast Surgery in the Advanced Multimodality Image Guided Operating Suite (AMIGO)

Stage I Breast Carcinoma | Stage II Breast Carcinoma

United States
Dana-Farber Cancer Institute

Completed

Effects of Exercise Intervention on Insulin Levels in Breast Cancer Survivors

Breast Cancer

United States
Dana-Farber Cancer Institute

Completed

A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors

Advanced Solid Tumor | Metastatic Solid Tumor

United States
Dana-Farber Cancer Institute

Completed

Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease

Graft vs Host Disease | Chronic Graft vs Host Disease | cGVHD

United States
Dana-Farber Cancer Institute

Completed

RPFNA Assessment of Exercise Effect in Breast Cancer

Breast Cancer

United States

Clinical Trials Sponsored by Dafna yahav

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations